Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Garcia Castillo (Madrid, Spain), T. Alonso Pérez (Madrid, Spain), J. Ancochea Bermúdez (Madrid, Spain), M. Pastor Sanz (Madrid, Spain), J. De Torres (Pamplona, Spain), B. Lamprecht (Linz, Austria), P. Almagro (Terrasa, Spain), P. Martínez Camblor (Hannover, United States of America), M. Miratvilles (Barcelona, Spain), M. Rodríguez Carballeira (terrasa, Spain), I. Alfageme (Sevilla, Spain), A. Ramirez Garcia-Luna, (San Luis de Potosí, Mexico), B. Kaiser (Linz, Austria), C. Casanova (Santa Cruz de Tenerife, Spain), C. Esteban (Vizcaya, Spain), J. Soler Cataluña (Valencia, Spain), B. Celi (Brighton, United States of America), J. Marín (Zaragoza, Spain), P. Sobradillo (Txagorritxu, Spain), P. Lange (Cophenague, Spain), J. Garcia Aymerich, (Barcelona, Spain), J. Anto (Barcelona, Spain), A. Turner (Birmingham, United Kingdom), H. Meilan (Michigan, United States of America), A. Laghammer (Trondheim, Norway), S. Vikjord (Levanger, Norway), A. Stenberg (Baltimore, United States of America), L. Leivseth (Tromso, Norway), A. Johannessen (Haukeland, Norway), O. Toru (Kyoto, Japan), B. Cosío (Palma de Mallorca, Spain), A. Echazarreta (Buenos Aires, Argentina), N. Roche (Paris, France), P. Burgel (Paris, France), D. Sin (Vancouver, Canada), M. Puhan (Zurich, Switzerland), J. López Campos (Sevilla, Spain), A. Navarro (Terrasa, Spain), L. Carrasco (Sevilla, Spain), P. Bakke (Bergen, Norway), J. Soriano (Madrid, Spain). Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging systems: a pooled analysis of individual patient data. 966

Member's Comments

No comment yet.

Related content which might interest you: Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data Source: ERJ Open Res, 6 (4) 00253-2020; 10.1183/23120541.00253-2020 Year: 2020 Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Implementation of the GOLD 2017 disease classification in a real-life COPD cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021 Distribution of COPD patients in the GOLD assessment framework by exacerbations Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003 Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study Source: Eur Respir J 2009; 34: 588 Year: 2009 The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Global initiative for chronic obstructive lung diseases (GOLD): time to act Source: Eur Respir J 2001; 18: 901-902 Year: 2001 GOLD classification of COPD and subsequent mortality: findings from a cohort study Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014